跳至主要内容

Isotope-labeled Internal Standards Synthesis

Medicilon provides synthesis services of standards and isotope internal standards, and offers professional services in the design, synthesis, preparation and release of radiolabeled compounds of synthetic routes.

 At the same time, Medicilon has the capability of isotope pharmacokinetic analysis of innovative drugs and has served the new drug development and marketing applications of many pharmaceutical companies. Medicilon has an advanced laboratory capable of isotope pharmacokinetic analysis of innovative drugs and an integrated service platform integrating isotope synthesis, labeling, testing, and analysis, providing comprehensive technical support for the research and development of new drugs such as antibodies and vaccines.



Services include:
  • 1. Synthesis services of standards and isotope internal standards
    Medicilon’s Chemical Synthesis and Radiosynthesis Laboratory can provide short-term and rapid synthesis services of standards and isotope internal standards. Synthesis services include but are not limited to isotope labeling position selection, synthesis route optimization, isotope product purification and analysis, and isotope labeling biomacromolecule R&D services.
  • 2. Pharmaceutical research and analysis services of radioisotope
    Pharmaceutical research and analysis services of radioisotope, using 3H、14C 、32P、33P 、125I、35S、89Zr and other radioactive isotopes for labeling experiments in the drug development process, including:
    Distribution, metabolism and pharmacokinetics of drugs in vivoRadioreceptor assayRadioligand binding testRadioactive uptake testingCell growth testRadioimmunoassayImmunoradiation analysis, etc.
    In addition,we have a radioisotope (125I, 14C, 3H) research license for studying material balance and tissue distribution.
  • 3. Synthesis of 14C and 3H radiolabeled compounds
    Medicilon can provide synthesis of aromatic compounds, heterocyclic compounds, polypeptides, oligonucleotides, conjugates, and polymers, including chiral compounds, antibody-drug conjugates (ADCs), and their linkers.Medicilon can provide a wide range of analytical methods and develop special technologies (including GLP analysis) such as Infrared spectroscopy, mass spectrometry, liquid chromatography (radioactivity detection and polymer characterization), gas chromatography, NMR differential scanning calorimetry, thermogravimetric analysis and ICP-MS, bioburden test and XRPD analysis.
Advantage:
  • Rich experience in chemical synthesis combined with efficient isotopic labeling chemistry.   Medicilon can provide customers with laboratories that comply with GLP and GMP standards to complete radiolabeled chemical projects.   Medicilon tracks the progress of isotope labeling chemistry and can quickly provide customers with a variety of isotope labeling intermediates.

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

What is Toxicokinetics?

Toxicokinetics  is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms  toxicokinetics ,  pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...